ROBICHAUD ALBERT

PrivateCIK: 1612861
Location

CAMBRIDGE, MA

ROBICHAUD ALBERT (Chief Scientific Officer) purchased 22.4% of their position (25K shares) of SAGE THERAPEUTICS, INC. on the open market

Open‑market purchase worth $1.60M — a significant purchase. The strongest form of insider conviction signal.

P · 1 purchase
InsiderROBICHAUD ALBERTCIK 1612861
IssuerSAGE THERAPEUTICS, INC.CIK 1597553
Officer· Chief Scientific Officer
Since Dec 2018
+25K
Net shares
Net buyer
$1.92M
Total acquired
1
Open market trades
1B · 0S
7
Total transactions
40.74K acquired · 15.74K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+6.93K

Price / share

$1.36

Trade value

$9.43K

% of position

7.2%
12/9/2019
95.66K102.59K

Common Stock

Direct
M · Option Exercise

Shares

+5.73K

Price / share

$38.25

Trade value

$219.25K

% of position

5.6%
12/9/2019
102.59K108.32K

Common Stock

Direct
M · Option Exercise

Shares

+3.08K

Price / share

$28.63

Trade value

$88.07K

% of position

2.8%
12/9/2019
108.32K111.40K

Common Stock

Direct
P · Purchase

Shares

+25K

Price / share

$64.16

Trade value

$1.60M

% of position

22.4%
12/9/2019
111.40K136.40K
Total

Net shares

+40.74K

Net value

$1.92M

Derivative Transactions3

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

6.93K shares

Shares

6.93K

Strike price

1.36

Held after

0.00

Exercisable

12/9/2019

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

5.73K shares

Shares

5.73K

Strike price

38.25

Held after

32.67K

Exercisable

12/9/2019

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

3.08K shares

Shares

3.08K

Strike price

28.63

Held after

21.92K

Exercisable

12/9/2019
ROBICHAUD ALBERT — Insider Transaction (Form 4) Filed Dec 10, 2019 | Finecho